Correlation Between Vincerx Pharma and Emmaus Life
Can any of the company-specific risk be diversified away by investing in both Vincerx Pharma and Emmaus Life at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vincerx Pharma and Emmaus Life into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vincerx Pharma and Emmaus Life Sciences, you can compare the effects of market volatilities on Vincerx Pharma and Emmaus Life and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vincerx Pharma with a short position of Emmaus Life. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vincerx Pharma and Emmaus Life.
Diversification Opportunities for Vincerx Pharma and Emmaus Life
0.75 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Vincerx and Emmaus is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding Vincerx Pharma and Emmaus Life Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Emmaus Life Sciences and Vincerx Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vincerx Pharma are associated (or correlated) with Emmaus Life. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Emmaus Life Sciences has no effect on the direction of Vincerx Pharma i.e., Vincerx Pharma and Emmaus Life go up and down completely randomly.
Pair Corralation between Vincerx Pharma and Emmaus Life
If you would invest 26.00 in Emmaus Life Sciences on September 2, 2024 and sell it today you would earn a total of 0.00 from holding Emmaus Life Sciences or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 1.56% |
Values | Daily Returns |
Vincerx Pharma vs. Emmaus Life Sciences
Performance |
Timeline |
Vincerx Pharma |
Emmaus Life Sciences |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Vincerx Pharma and Emmaus Life Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Vincerx Pharma and Emmaus Life
The main advantage of trading using opposite Vincerx Pharma and Emmaus Life positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vincerx Pharma position performs unexpectedly, Emmaus Life can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Emmaus Life will offset losses from the drop in Emmaus Life's long position.Vincerx Pharma vs. Tff Pharmaceuticals | Vincerx Pharma vs. Eliem Therapeutics | Vincerx Pharma vs. Inhibrx | Vincerx Pharma vs. Enliven Therapeutics |
Emmaus Life vs. NRx Pharmaceuticals | Emmaus Life vs. Cell Source | Emmaus Life vs. Anebulo Pharmaceuticals | Emmaus Life vs. Adagene |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Complementary Tools
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Equity Valuation Check real value of public entities based on technical and fundamental data |